Friday 9th February, at the INL Auditorium This seminar is an event organized in the framework of the Annual Meeting of the project 3DNeoNet, led by the University College of Dublin (UCD), and in which INL is part of the Consortium. The overall goal of 3DNeoNet is the improvement of available treatments for cancer and ocular disease by enhancing drug discovery-development and delivery to targeted tissues, through advanced international co-operation between academic and non-academic partners. The interdisciplinary expertise provided by 18 partners in 7 countries encompasses among others: drug screens, ADME, toxicology, preclinical models, nanotechnology, biomaterials and clinical trials. There will be three internationally recognized speakers with outstanding contributions in the fields of drug delivery, cancer therapy, and polymer chemistry: Prof. María José Alonso (University of Santiago de Compostela, USC), Prof. Vitaliy Khutoryanskiy (University of Reading, UoR), and Bruno Sarmento (Institute for Investigation and Innovation in Health (i3S)/INEB). After their talks, there will be a Round Table, entitled: Challenges of the start-ups in the health/ pharma industry. From the idea to the market, chaired by Breandan Kennedy (UCD), Head of the 3DNeoNet Industry-Academia consortium, and Beatriz de la Parra, founder of the company ECM Ingeniería Ambiental S.L.(Spain). View Program Advanced […]
Read more